{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:45:06Z","timestamp":1790628306481,"version":"4.1.0"},"reference-count":59,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T00:00:00Z","timestamp":1661558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Introduction. Chronic low-grade inflammation is a characteristic of women with polycystic ovary syndrome (PCOS), although this may be obesity-driven rather than an intrinsic facet of PCOS; furthermore, vitamin D deficiency, another common feature of PCOS, is reported to have an association with increased inflammation. Therefore, circulating inflammatory protein levels and circulating levels of vitamin D may be linked in PCOS, though it is unclear which vitamin D metabolites may be important. Methods. We measured plasma levels of 24 inflammatory proteins and 12 matrix metalloproteinases (proteins modulated by the inflammatory process) by slow off-rate modified aptamer (SOMA)-scan plasma protein measurement in weight and aged-matched non-obese non-insulin resistant PCOS (n = 24) and control (n = 24) women. Inflammatory proteins and matrix metalloproteinases were correlated to 25-hydroxy vitamin D3 (25(OH)D3), its epimer 25-hydroxy-3epi-vitamin D (3epi25(OH)D) and the active 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) as measured by gold standard isotope-dilution liquid chromatography tandem mass spectrometry. Results. PCOS women had both an elevated free androgen index and circulating anti-mullerian hormone, though insulin resistance was comparable to controls. C-reactive protein, as a standard circulatory marker of inflammation, was comparable between cohorts. Levels of circulating inflammatory proteins and matrix metalloproteinases were not different between the PCOS and control women, with no correlation of 25(OH)D3, 1,25(OH)2D3 or 3epi25(OH)D with any of the inflammatory proteins. Conclusion. In a non-obese PCOS population matched for age and insulin resistance, circulating inflammatory proteins and matrix metalloproteinases were not elevated and did not correlate with 25(OH)D3, its epimer 3epi25(OH)D or 1,25(OH)2D3 in either control or PCOS women, indicating that the inflammatory response is absent and the vitamin D-metabolite independent in non-obese women with PCOS.<\/jats:p>","DOI":"10.3390\/nu14173540","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T22:53:42Z","timestamp":1661813622000},"page":"3540","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Inflammatory Markers in Non-Obese Women with Polycystic Ovary Syndrome Are Not Elevated and Show No Correlation with Vitamin D Metabolites"],"prefix":"10.3390","volume":"14","author":[{"given":"Abu Saleh Md","family":"Moin","sequence":"first","affiliation":[{"name":"Royal College of Surgeons in Ireland Bahrain, Adliya 15503, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3544-2231","authenticated-orcid":false,"given":"Thozhukat","family":"Sathyapalan","sequence":"additional","affiliation":[{"name":"Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull YO10 5DD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Atkin","sequence":"additional","affiliation":[{"name":"Royal College of Surgeons in Ireland Bahrain, Adliya 15503, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5762-3917","authenticated-orcid":false,"given":"Alexandra E.","family":"Butler","sequence":"additional","affiliation":[{"name":"Royal College of Surgeons in Ireland Bahrain, Adliya 15503, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1530\/EJE-11-0755","article-title":"Recent advances in cardiovascular aspects of polycystic ovary syndrome","volume":"166","author":"Sathyapalan","year":"2012","journal-title":"Eur. J. Endocrinol. Eur. Fed. Endocr. Soc."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Carter, A.M. (2012). Complement activation: An emerging player in the pathogenesis of cardiovascular disease. Scientifica, 2012.","DOI":"10.6064\/2012\/402783"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.fertnstert.2010.11.036","article-title":"Circulating inflammatory markers in polycystic ovary syndrome: A systematic review and metaanalysis","volume":"95","author":"Gonzalez","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"758656","DOI":"10.1155\/2010\/758656","article-title":"Mediators of inflammation in polycystic ovary syndrome in relation to adiposity","volume":"2010","author":"Sathyapalan","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3109\/09513590.2016.1155208","article-title":"Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome","volume":"32","author":"Bastu","year":"2016","journal-title":"Gynecol. Endocrinol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1210\/jc.2003-031096","article-title":"Increased C-reactive protein levels in the polycystic ovary syndrome: A marker of cardiovascular disease","volume":"89","author":"Boulman","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejogrb.2015.06.022","article-title":"Obesity and inflammatory biomarkers in women with polycystic ovary syndrome","volume":"192","author":"Shen","year":"2015","journal-title":"Eur. J. Obs. Gynecol. Reprod. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejogrb.2016.06.022","article-title":"Evaluation of hs-CRP and visseral adiposity index in patients with policystic ovary syndrome by clinical and laboratory findings","volume":"204","author":"Un","year":"2016","journal-title":"Eur. J. Obs. Gynecol. Reprod. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Aboeldalyl, S., James, C., Seyam, E., Ibrahim, E.M., Shawki, H.E., and Amer, S. (2021). The Role of Chronic Inflammation in Polycystic Ovarian Syndrome-A Systematic Review and Meta-Analysis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052734"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0026-0495(99)90100-2","article-title":"Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome","volume":"48","author":"Gonzalez","year":"1999","journal-title":"Metabolism"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1530\/REP-15-0340","article-title":"Matrix metalloproteinases 2 and 9 and MMP9\/NGAL complex activity in women with PCOS","volume":"151","author":"Ranjbaran","year":"2016","journal-title":"Reproduction"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.2741\/1409","article-title":"MMPS and TIMPS in ovarian physiology and pathophysiology","volume":"9","author":"Goldman","year":"2004","journal-title":"Front. Biosci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11010-011-0793-6","article-title":"Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome","volume":"353","author":"Gomes","year":"2011","journal-title":"Mol. Cell. Biochem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1210\/jc.2005-0648","article-title":"Increased circulating levels of matrix metalloproteinase-2 and -9 in women with the polycystic ovary syndrome","volume":"91","author":"Lewandowski","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijgo.2006.11.012","article-title":"Elevated serum levels of matrix metalloproteinase-2 in women with polycystic ovarian syndrome","volume":"96","author":"Liu","year":"2007","journal-title":"Int. J. Gynaecol. Obs."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/09513590802056995","article-title":"Raised serum levels of matrix metalloproteinase-9 in women with polycystic ovary syndrome and its association with insulin-like growth factor binding protein-1","volume":"24","author":"Liu","year":"2008","journal-title":"Gynecol. Endocrinol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1530\/EJE-07-0822","article-title":"Serum concentrations of atherogenic proteins neutrophil gelatinase-associated lipocalin and its complex with matrix metalloproteinase-9 are significantly lower in women with polycystic ovary syndrome: Hint of a protective mechanism?","volume":"158","author":"Livadas","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"638621","DOI":"10.3389\/fendo.2021.638621","article-title":"Vitamin D Association with Macrophage-Derived Cytokines in Polycystic Ovary Syndrome: An Enhanced Risk of COVID-19 Infection?","volume":"12","author":"Moin","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nri3499","article-title":"Metalloproteinases and their natural inhibitors in inflammation and immunity","volume":"13","author":"Khokha","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Rudnicka, E., Suchta, K., Grymowicz, M., Calik-Ksepka, A., Smolarczyk, K., Duszewska, A.M., Smolarczyk, R., and Meczekalski, B. (2021). Chronic low grade inflammation in pathogenesis of PCOS. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073789"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-2006-948308","article-title":"Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome","volume":"114","author":"Hahn","year":"2006","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.metabol.2011.03.002","article-title":"Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome","volume":"60","author":"Li","year":"2011","journal-title":"Metab. Clin. Exp."},{"key":"ref_23","first-page":"Cd007470","article-title":"Vitamin D supplementation for prevention of mortality in adults","volume":"Jan 10","author":"Bjelakovic","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_24","first-page":"335","article-title":"Association of serum vitamin D levels with chronic disease and mortality","volume":"37","year":"2020","journal-title":"Nutr. Hosp."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"105892","DOI":"10.1016\/j.jsbmb.2021.105892","article-title":"Vitamin D deficiency effects on cardiovascular parameters in women with polycystic ovary syndrome: A retrospective, cross-sectional study","volume":"211","author":"Butler","year":"2021","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1530\/EJE-11-0984","article-title":"Vitamin D and fertility: A systematic review","volume":"166","author":"Lerchbaum","year":"2012","journal-title":"Eur. J. Endocrinol. Eur. Fed. Endocr. Soc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/BF03345785","article-title":"The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome","volume":"33","author":"Selimoglu","year":"2010","journal-title":"J. Endocrinol. Investig."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1530\/EJE-13-0617","article-title":"The role of vitamin D in metabolic disturbances in polycystic ovary syndrome (PCOS): A systematic review","volume":"169","author":"Snackey","year":"2013","journal-title":"Eur. J. Endocrinol. Eur. Fed. Endocr. Soc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00011-014-0755-z","article-title":"Inflammation and vitamin D: The infection connection","volume":"63","author":"Mangin","year":"2014","journal-title":"Inflamm. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.chembiol.2013.12.016","article-title":"Vitamin D metabolism, mechanism of action, and clinical applications","volume":"21","author":"Bikle","year":"2014","journal-title":"Chem. Biol."},{"key":"ref_31","first-page":"119","article-title":"Metabolism of vitamin D3 by cytochromes P450","volume":"10","author":"Sakaki","year":"2005","journal-title":"Front. Biosci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1152\/physrev.00014.2015","article-title":"Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects","volume":"96","author":"Christakos","year":"2016","journal-title":"Physiol. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"15897","DOI":"10.1074\/jbc.M311473200","article-title":"C-3 epimerization of vitamin D3 metabolites and further metabolism of C-3 epimers: 25-hydroxyvitamin D3 is metabolized to 3-epi-25-hydroxyvitamin D3 and subsequently metabolized through C-1alpha or C-24 hydroxylation","volume":"279","author":"Kamao","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.cca.2011.05.010","article-title":"Isotope dilution ultra performance liquid chromatography-tandem mass spectrometry method for simultaneous measurement of 25-hydroxyvitamin D2, 25-hydroxyvitamin D3 and 3-epi-25-hydroxyvitamin D3 in human serum","volume":"412","author":"Schleicher","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Al-Zohily, B., Al-Menhali, A., Gariballa, S., Haq, A., and Shah, I. (2020). Epimers of Vitamin D: A Review. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21020470"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2040622320924159","DOI":"10.1177\/2040622320924159","article-title":"Association of vitamin D(3) and its metabolites in patients with and without type 2 diabetes and their relationship to diabetes complications","volume":"11","author":"Butler","year":"2020","journal-title":"Ther. Adv. Chronic Dis."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Molnar, F., Sigueiro, R., Sato, Y., Araujo, C., Schuster, I., Antony, P., Peluso, J., Muller, C., Mourino, A., and Moras, D. (2011). 1alpha,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: Its synthesis, biological activity and crystal structure with its receptor. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0018124"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/ajcn\/72.3.690","article-title":"Decreased bioavailability of vitamin D in obesity","volume":"72","author":"Wortsman","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fendo.2019.00013","article-title":"Association of Vitamin D Metabolites With Embryo Development and Fertilization in Women With and Without PCOS Undergoing Subfertility Treatment","volume":"10","author":"Cunningham","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod., 19, 41\u201347.","DOI":"10.1093\/humrep\/deh098"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Webb, A.R., Kazantzidis, A., Kift, R.C., Farrar, M.D., Wilkinson, J., and Rhodes, L.E. (2018). Meeting Vitamin D Requirements in White Caucasians at UK Latitudes: Providing a Choice. Nutrients, 10.","DOI":"10.3390\/nu10040497"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1038\/s41598-020-61531-z","article-title":"Effect of induced hypoglycemia on inflammation and oxidative stress in type 2 diabetes and control subjects","volume":"10","author":"Kahal","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Kraemer, S., Vaught, J.D., Bock, C., Gold, L., Katilius, E., Keeney, T.R., Kim, N., Saccomano, N.A., Wilcox, S.K., and Zichi, D. (2011). From SOMAmer-based biomarker discovery to diagnostic and clinical applications: A SOMAmer-based, streamlined multiplex proteomic assay. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0026332"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.fertnstert.2011.11.036","article-title":"Should all women with PCOS be treated for insulin resistance?","volume":"97","author":"Marshall","year":"2012","journal-title":"Fertil. Steril."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejogrb.2011.07.012","article-title":"Low-grade chronic inflammation in the peripheral blood and ovaries of women with polycystic ovarian syndrome","volume":"159","author":"Xiong","year":"2011","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e2152","DOI":"10.1210\/clinem\/dgaa108","article-title":"Inflammation triggered by saturated fat ingestion is linked to insulin resistance and hyperandrogenism in polycystic ovary syndrome","volume":"105","author":"Considine","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.steroids.2011.10.013","article-title":"Tissue physiology and pathology of aromatase","volume":"77","author":"Stocco","year":"2012","journal-title":"Steroids"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3389\/fphys.2019.01607","article-title":"Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes","volume":"Jan 29","author":"Zatterale","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1161\/CIRCRESAHA.119.315896","article-title":"Metabolic Inflammation and Insulin Resistance in Obesity","volume":"126","author":"Wu","year":"2020","journal-title":"Circ. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e000741","DOI":"10.1136\/bmjdrc-2019-000741","article-title":"Relationship of obesity to adipose tissue insulin resistance","volume":"8","author":"Jiang","year":"2020","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Legro, R.S. (2012). Obesity and PCOS: Implications for diagnosis and treatment. Seminars in Reproductive Medicine, Thieme Medical Publishers.","DOI":"10.1055\/s-0032-1328878"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1038\/s41598-021-84586-y","article-title":"Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome","volume":"11","author":"Moin","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"18895","DOI":"10.1038\/s41598-020-75109-2","article-title":"Metabolic comparison of polycystic ovarian syndrome and control women in Middle Eastern and UK Caucasian populations","volume":"10","author":"Butler","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_54","first-page":"244","article-title":"Vitamin D in inflammatory diseases","volume":"5","author":"Wobke","year":"2014","journal-title":"Front. Physiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3389\/fimmu.2020.01543","article-title":"Associations Between Complement Components and Vitamin D and the Physical Activities of Daily Living Among a Longevous Population in Hainan, China","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"169","DOI":"10.21037\/apm-20-2201","article-title":"Vitamin D improves levels of hormonal, oxidative stress and inflammatory parameters in polycystic ovary syndrome: A meta-analysis study","volume":"10","author":"Zhao","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13048-019-0480-x","article-title":"Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome","volume":"12","author":"Ostadmohammadi","year":"2019","journal-title":"J. Ovarian Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.2337\/dc20-1115","article-title":"Renin-Angiotensin System Overactivation in Type 2 Diabetes: A Risk for SARS-CoV-2 Infection?","volume":"43","author":"Moin","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/cen.14322","article-title":"Complement activation in polycystic ovary syndrome occurs in the postprandial and fasted state and is influenced by obesity and insulin sensitivity","volume":"94","author":"Lewis","year":"2021","journal-title":"Clin. Endocrinol."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/14\/17\/3540\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:16:31Z","timestamp":1760141791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/14\/17\/3540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,27]]},"references-count":59,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["nu14173540"],"URL":"https:\/\/doi.org\/10.3390\/nu14173540","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,27]]}}}